INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 459m ago
HOUSE PTR59m ago
SEC 13F59m ago
ROBINHOOD CHAIN58m ago
SEC FORM 4/Disposition to issuerVerified data

Chiang Pichi Luo reported KZR

SVP, Corporate Controller · Kezar Life Sciences, Inc. · Kezar Life Sciences, Inc. — Employee Stock Option (right to buy)

Side
D
Value
—
Shares
2,899
Price
—
Executed
May 11, 2026
Disclosed
May 11, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
May 11 executedMay 11, 2026 disclosed

KZR · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Disposition to issuer — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 0 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · KZR

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    CL
    Chiang Pichi LuoSVP, Corporate Controller
    KZRKezar Life Sciences, Inc.
    Tender of shares
    		U—
    2,711 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CL
    Chiang Pichi LuoSVP, Corporate Controller
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    10.0K sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CL
    Chiang Pichi LuoSVP, Corporate Controller
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    12.5K sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CL
    Chiang Pichi LuoSVP, Corporate Controller
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    7,500 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CL
    Chiang Pichi LuoSVP, Corporate Controller
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    1,199 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CL
    Chiang Pichi LuoSVP, Corporate Controller
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    599 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CL
    Chiang Pichi LuoSVP, Corporate Controller
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    2,401 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CL
    Chiang Pichi LuoSVP, Corporate Controller
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    2,499 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CL
    Chiang Pichi LuoSVP, Corporate Controller
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    2,899 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CL
    Chiang Pichi LuoSVP, Corporate Controller
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    4,999 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CL
    Chiang Pichi LuoSVP, Corporate Controller
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    7,999 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    SC
    Schiller Mark C.Chief Operating Officer
    KZRKezar Life Sciences, Inc.
    Tender of shares
    		U—
    2,739 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    SC
    Schiller Mark C.Chief Operating Officer
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    25.0K sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    SC
    Schiller Mark C.Chief Operating Officer
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    24.5K sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    SC
    Schiller Mark C.Chief Operating Officer
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    12.0K sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    SC
    Schiller Mark C.Chief Operating Officer
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    4,999 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    SC
    Schiller Mark C.Chief Operating Officer
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    2,499 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    SC
    Schiller Mark C.Chief Operating Officer
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    5,249 sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    SC
    Schiller Mark C.Chief Operating Officer
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    13.0K sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    9
    SC
    Schiller Mark C.Chief Operating Officer
    KZRKezar Life Sciences, Inc.
    Disposition to issuer
    		D—
    16.5K sh
    		May 11, 2026May 11, 2026
    traded May 11, 2026
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002064744-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    May 11, 2026
    Published
    May 11, 2026
    Ingested by INSIDER
    Nov 5, 03:59 UTC
    Last re-read
    Nov 5, 03:59 UTC

    Extracted facts

    Filer
    Chiang Pichi Luo
    Role
    SVP, Corporate Controller
    Transaction
    Disposition to issuerAs filed: “D”
    Asset
    Kezar Life Sciences, Inc. — Employee Stock Option (right to buy)
    Ticker
    KZR
    Shares
    2,899
    Price per share
    $0
    Execution date (reported)
    May 11, 2026
    Owned after transaction
    0 shares
    Days from execution to publication
    0

    What this establishes

    Chiang Pichi Luo filed this Form 4 reporting a disposition to issuer of KZR on May 11, 2026. It became public on May 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    SVP, Corporate Controller
    Chiang Pichi Luocik:0002064744
    Issuer
    Kezar Life Sciences, Inc.cik:0001645666

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.

    Source error

    Price history for KZR is unavailable.

    An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.